Pathway Therapeutics Garners $200,000 New Financing

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=07be8fdf-a2a1-4436-b892-ac9b85c99f50&Preview=1
Date
11/30/2012
Company Name
Pathway Therapeutics
Mailing Address
409 Illinois Street San Francisco, CA 94158
Company Description
Pathway Therapeutics is a clinical stage, privately held, pharmaceutical company developing differentiated and best in class isoform specific PI3-kinase (PI3K) inhibitors for oncology, inflammatory and respiratory diseases.
Website
http://www.pathwaytx.com
Transaction Type
Debt
Transaction Amount
$200,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing.
M&A Terms
Venture Investor
Undisclosed